大阪ソーダ(4046) – Osaka Soda Announces Revisions to the Full-Year Earnings Forecast and Dividend Forecast for the Fiscal Year Ending March 31, 2022

URLをコピーする
URLをコピーしました!

開示日時:2022/04/18 17:00:00

損益

決算期 売上高 営業益 経常益 EPS
2018.03 10,123,100 731,900 731,700 178.58
2019.03 10,787,400 948,900 949,200 254.24
2020.03 10,547,700 969,900 1,001,300 244.16
2021.03 9,726,600 834,100 835,700 230.23

※金額の単位は[万円]

株価

前日終値 50日平均 200日平均 実績PER 予想PER
3,050.0 2,839.58 2,651.32 9.76 10.45

※金額の単位は[円]

キャッシュフロー

決算期 フリーCF 営業CF
2018.03 294,700 775,700
2019.03 615,000 985,400
2020.03 682,900 1,033,600
2021.03 751,700 934,700

※金額の単位は[万円]

▼テキスト箇所の抽出

April 18, 2022 For Immediate Release To whom it may concern, Company name: OSAKA SODA Co., LTD. Securities Code: TSE Prime Market 4046 Representative: Kenshi Terada, Representative Director, Chief Executive Officer For inquiry: Toru Imamura, General Manager, Administration Division Tel: +81-(0)6-6110-1560 Osaka Soda Announces Revisions to the Full-Year Earnings Forecast and Dividend Forecast for the Fiscal Year Ending March 31, 2022 Based on recent performance trends, Osaka Soda (the “Company”) hereby announces the revisions to the full-year consolidated earnings forecast and dividend forecast for the fiscal year ending March 31, 2022 (“Fiscal 2021”), which were announced on Oct 19, 2021. 1. Revisions to consolidated earnings forecast (1) Revisions to consolidated earnings forecast for Fiscal 2021 (April 1, 2021 – March 31, 2022) Net Sales Operating Ordinary Net Income Earnings Income Income attributable to per share (Millions of yen; unless otherwise noted) owners of the (yen) parent 82,000 88,000 6,000 7.3% 10,700 12,400 1,700 15.9% 11,400 13,400 2,000 17.5% 8,000 9,500 1,500 18.8% 342.95 407.20 – – Previous Results for 97,266 8,341 8,838 6,050 257.37 Previous Forecast (A) Revised Forecast (B) Change (B-A) Change (%) (Reference) Fiscal 2020 1 / 2 (Note) As the Company has applied the “Accounting Standard for Revenue Recognition” (ASBJ Statement No.29), etc. from the beginning of the first quarter of the Fiscal 2021, the above consolidated earnings forecast is the figures after the relevant accounting standards is adopted. (2) Reason for the revision Net sales of Epichlorohydrin and Allyl Ether have exceeded our expectations mainly for electronic materials and Healthcare business has continued favorably due to the expansion of the adaption of new grades regarding purification materials for pharmaceuticals and the acquisition of new projects regarding pharmaceutical intermediates. Based on these results, we will revise upward our forecast for Fiscal 2021, which were announced on Oct 19, 2021, as described above. The adjusted full-year earnings will be expected to be about 50-60 % increase respectively compared with the previous fiscal year and to become the highest profits ever. 2. Revision to the dividend forecast (1) Revision to the dividend forecast Previous Forecast Revised Forecast Previous Results for Fiscal 2020 (2) Reason for the revision Annual Dividends (yen) End of first half End of fiscal year Total 35.00 – 32.50 35.00 45.00 32.50 70.00 80.00 65.00 In the light of the above revisions to earnings forecast, the Company will revise the year-ended dividend to be 45.00 yen per share, an increase of 10.00 yen from the previous forecast 35.00 yen, taking into the account the continuity of stable dividends and retained earnings for future business development. As a result, the annual dividend per share is 80.00 yen, an increase of 15.00 yen compared to the previous fiscal year. (Note) The above-mentioned forecasts are based on information currently available to the Company. Actual results may differ from the forecasts due to various factors in the future. 2 / 2

この記事が気に入ったら
いいね または フォローしてね!

シェアしたい方はこちらからどうぞ
URLをコピーする
URLをコピーしました!